Healthcare - Biotechnology - NASDAQ - US
$ 11.14
-3.88 %
$ 499 M
Market Cap
-20.63
P/E
Price Target
Average
108.71%
Revenue Forecast
Estimate
13.92%
EBIT
Estimate
--26.65%
Net Income
Estimate
--22.81%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Y-mAbs Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for YMAB of $23.2 , with forecasts ranging from a low of $21 to a high of $26 .
YMAB Lowest Price Target
Wall Street Target
21 USD
88.51%
YMAB Average Price Target
Wall Street Target
23.2 USD
108.71%
YMAB Highest Price Target
Wall Street Target
26 USD
133.39%
REVENUE FORECAST
Revenue Forecast Chart YMAB
EBIT FORECAST
EBIT Forecast Chart YMAB
NET INCOME FORECAST
Net Income Chart YMAB